Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02371720 · ClinicalTrials.gov registry record · NA
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT02371720 is a NA study that has completed, run by Emory University. The registered enrollment target is 164 participants.
The verdict
NCT02371720, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
The purpose of this research study is to learn about ways to help children and adults with sickle cell disease who are taking the medication, hydroxyurea.
Interventions
- BEHAVIORAL Mobile DOT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2014-06-01 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02371720
The ClinicalTrials.gov registry entry for NCT02371720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile DOT is the first listed.
NCT02371720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02371720 about?
NCT02371720 is a clinical study titled "Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease". The purpose of this research study is to learn about ways to help children and adults with sickle cell disease who are taking the medication, hydroxyurea.
What is the current status of trial NCT02371720?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2014-06-01. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT02371720?
The interventions under investigation include: Mobile DOT (BEHAVIORAL).
Who is sponsoring clinical trial NCT02371720?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.